av/lipocine--big.svg

NASDAQ:LPCN

Lipocine

  • Stock

USD

Last Close

2.64

06/11 21:00

Market Cap

40.38M

Beta: 0.94

Volume Today

10.22K

Avg: 201.21K

PE Ratio

−1.28

PFCF: −1.78

    Description

    Lipocine Inc., a clinical-stage biopharmaceutical company, focuses on the development of pharmaceutical products for the treatment of neuroendocrine and metabolic disorders. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Its lead product candidate is TLANDO, an oral testosterone replacement therapy. The company's p...Show More

    Earnings

    Earnings per Share (Estimate*)

    -4-3-2-11232019-03-062020-08-062021-12-312023-11-082024-11-13

    Revenue (Estimate*)

    50M100M150M200M2019-03-062020-08-062021-12-312023-11-082024-11-13

    *Estimate based on analyst consensus